Stephen L. Leib

Stephen L. Leib, MD, Full Professor for Clinical Microbiology and Director of the Institute for Infectious Diseases, University of Bern. Swiss Citizen. Medical School (1982-88) and doctoral thesis (Dr. med.) at the Medical Faculty, University Basel, Switzerland. Post-Graduate Course in Experimental Medicine and Biology; Swiss Federal Institute of Technology / University Zurich, Switzerland (1989 – 1991). Specialization in Internal Medicine (Board certified FMH 1995) and in Infectious Diseases (Board certified FMH 1999), University Hospitals of Basel, Basel, Switzerland. Research Fellowship (1994-96) at the Departments of Medicine and Neurology, San Francisco General Hospital, University of California San Francisco, San Francisco, CA, USA. Consultant in Infectious Diseases, University Hospitals Basel, Basel, Switzerland (1996-1997). Consultant Attending Physician, Infectious Diseases, University Hospital (Insel-group Hospitals), Bern, Bern, Switzerland. Principal Investigator and Head, Neuroinfection Laboratory, Institute for Infectious Diseases, University of Bern, Bern, Switzerland (1997- 2012), with “Habilitation” in Experimental Infectiology (2001). Professorship (Förderungsprofessur) by the Swiss National Science Foundation (2002-2006). Head, Division of Biology, Spiez Laboratory, Swiss Federal Office for Civil Protection, Spiez, Switzerland (2012-2015). Since 2015, Director of the Institute for Infectious Diseases, University of Bern. Among other academic and administrative services, he serves as executive committee member, Swiss Society for Infectious Diseases (SSI 1997-present), Founder, Past-Chair, treasurer, Study group for Infectious diseases of the brain (ESGIB), European Society for Clinical Microbiology & Infectious Diseases (ECCMID) (ESGIB; 1997-present), Member of the permanent extra-parliamentary Swiss federal commission for NBC protection elected by the Federal Council (KomABC 2015-present). Research interests: Infectious Diseases of the central nervous system, host pathogen interactions, emerging infectious diseases, innovative diagnostics.